Floatz logo

TENOFOVIR DISOPROXIL FUMARATE

HEPATITIS B CHRONIC

Ningbo No.2 HospitalSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the HEPATITIS B CHRONIC cohort.

Asset / SponsorPhaseRating
Entecavir
Beijing Continent Pharmaceutical Co, Ltd.
Phase 4BBB
Lamivudine
Yonsei University
Phase 4BBB
TENOFOVIR DISOPROXIL FUMARATE
Ningbo No.2 Hospital
Phase 4BBB
Telbivudine
The Fifth People's Hospital of Suzhou
Phase 4BBB
Tenofovir Alafenamide
Ningbo No.2 Hospital
Phase 4BB

View all 29 →

Same molecule, other indications

TENOFOVIR DISOPROXIL FUMARATE is also rated in:

chronic hepatitis B virus infectionDormant
BBB
Indicative ·
72 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
lipodystrophyDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →